New Delhi, Dec 15 (KNN) The Government of India, through the Bureau of Indian Standards (BIS), Department of Consumer Affairs, is phase wise implementing Quality Control Orders (QCOs) while providing ...
Lucknow, Dec 18 (KNN) Minister of State for Petroleum and Natural Gas, Suresh Gopi, informed the Lok Sabha on Thursday that no monthly or annual targets have been set for establishing or expanding ...
Mumbai, Dec 16 (KNN) The government has proposed the development of a Multi-Modal Logistics Park (MMLP) in Nashik, Maharashtra, aimed at improving supply chain efficiency and reducing logistics costs ...
New Delhi, Dec 13 (KNN) The Supreme Court has clarified that under the Insolvency and Bankruptcy Code (IBC), a 'pre-existing dispute' capable of blocking the initiation of a Corporate Insolvency ...
New Delhi, Oct 13 (KNN) The government is set to introduce a new interest subvention scheme aimed exclusively at MSME exporters, providing a 3% interest rebate on export credit. This move is designed ...
New Delhi, Nov 8 (KNN) A high-level government committee has recommended the cancellation, suspension, and deferment of Quality Control Orders (QCOs) for more than 200 products, citing concerns that ...
New Delhi, Jun 30 (KNN) Credit growth among Scheduled Commercial Banks has decelerated significantly to 9.6 percent as of June 13, 2025, representing a substantial decline from the 19.1 percent growth ...
New Delhi, Sep 3 (KNN) The Delhi High Court has directed the Central Board of Indirect Taxes and Customs (CBIC) and the Commissioner of Customs to consider providing preferential treatment to ...
New Delhi, Jun 24 (KNN) Chennai-based composite manufacturing technology start-up Fabheads has completed a USD 10 million Series A funding round led by Accel, with participation from Trifecta Capital.
New Delhi, June 23 (KNN) The Directorate General of Foreign Trade (DGFT) has clarified on Issuance of Preferential Certificate of Origin (COO) for India’s exports to Vietnam under the ASEAN-India Free ...
Ahmedabad, Apr 28 (KNN) Gujarat has reinforced its status as India's pharmaceutical leader by approving 183 new allopathic drug manufacturing facilities in the fiscal year 2024–25, the highest number ...